Home > Items where lead contributor is EMCDDA

Up a level
Export as
Group by: Item Type | No Grouping
Number of items: 136.

News

[EMCDDA] New legislation published today to bring faster response to new drugs. (21 Nov 2017)

[EMCDDA] Furanylfentanyl to be placed under control across the EU. (15 Nov 2017)

[EMCDDA] Preventing and reducing drug overdoses — a priority for the EMCDDA. (31 Aug 2017)

[EMCDDA] EMCDDA and ECDC join forces to address the challenge of hepatitis. (13 Jun 2017)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Monitoring hospital emergencies and acute drug toxicity in Europe: Euro-DEN Plus network expands reach by welcoming eight new centres. (09 Mar 2017)

[EMCDDA] EU Council adopts its position on the reform of the new psychoactive substances legislation. (09 Dec 2016)

[EMCDDA] Minimum quality standards for drug demand reduction interventions in the EU. (28 Sep 2015)

[EMCDDA] Gaps in HIV prevention expose Europe to risk of outbreaks. (01 Dec 2014)

[EMCDDA] Four new drugs to be placed under control. (24 Sep 2014)

[EMCDDA] Family can play vital role in addressing substance use disorders among adolescents. (06 Feb 2014)

[EMCDDA] EMCDDA hosts kick-off meeting of EC-funded Joint Action on Reducing Alcohol Related Harm. (31 Jan 2014)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Driving under the influence of drugs, alcohol and medicines. New EMCDDA report reveals risks of substance use behind the wheel. (14 Dec 2012)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] New ESPAD study shows overall stable drug use among school students and a reduction in ‘heavy episodic drinking’, but no decrease in cigarette smoking. (31 May 2012)

[EMCDDA] Drug use in Europe still a major threat to public health. (23 Jun 2011)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Developing a set of indicators on drug markets, crime and supply reduction in Europe: your input is welcome. (13 May 2011)

EMCDDA, EUROPOL. [EMCDDA] New drugs becoming available at ‘unprecedented pace’, says report. (11 May 2011)

[EMCDDA] EU drugs agency launches new guidelines for HIV testing in injecting drug users. (01 Dec 2010)

[EMCDDA] Council asks EMCDDA to assess risks of BZP. (24 Mar 2007)

Evidence resource

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2018) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl). Luxembourg: Publications Office of the European Union. 16 p.

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2018) EMCDDA–Europol joint report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]acetamide (methoxyacetylfentanyl). Luxembourg: Office for Official Publications of the European Communities. 16 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 50 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Developing drug supply monitoring in Europe: current concepts. Luxembourg: Publications Office of the European Union. 11 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 49 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Drug testing in schools. Luxembourg: Office for Official Publications of the European Communities. 17 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) New developments in national drug strategies in Europe. Luxembourg: Publications Office of the European Union. 23 p.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Systematic review on active case finding of communicable diseases in prison settings. Stockholm: ECDC. 50 p.

Almeida, Sara Rafael and Lourenço, Joana Sousa and Ciriolo, Emanuele [EMCDDA] . (2017) Applying behavioural insights to drug policy and practice: opportunities and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 20 p.

Brunt, Tibor [EMCDDA] . (2017) Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 21 p.

Blankers, Matthijs and Mujcic, Ajla [EMCDDA] . (2017) E-health and m-health: using new technologies to respond to drug problems. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Evaluating drug policy: a seven-step guide to support the commissioning and managing of evaluations. Luxembourg: Publications Office of the European Union. 30 p.

Sumnall, Harry and Bates, Geoff and Jones, Lisa [EMCDDA] . (2017) Evidence review summary: drug demand reduction, treatment and harm reduction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 25 p.

Bowden-Jones, O [EMCDDA] . (2017) Joining up sexual health and drug services to better meet client needs. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 13 p.

Lemmens, Paul and Dupont, Hans and Roosen, Inez [EMCDDA] . (2017) Migrants, asylum seekers and refugees: an overview of the literature relating to drug use and access to services. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 16 p.

Kilmer, Beau [EMCDDA] . (2017) New developments in cannabis regulation. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 25 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Adult family members of people with drug problems. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Local communities. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Migrants, refugees and asylum seekers. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Nightlife, festivals and other recreational settings. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Older people with problematic opioid use. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Prisons and the criminal justice system. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Schools and colleges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Vulnerable young people. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Women with drug problems. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Workplaces. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Dale-Perera, annette [EMCDDA] . (2017) Recovery, reintegration, abstinence, harm reduction: the role of different goals within the drug treatment in the European context. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 17 p.

Johnstone, Lauren and Liddell, David and Browne, Katie and Priyadarshi, Saket [EMCDDA] . (2017) Responding to the needs of ageing drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 14 p.

Webster, Russell [EMCDDA] . (2017) User-led interventions: an expanding resource? Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 14 p.

Arpa, Sharon [EMCDDA] . (2017) Women who use drugs: Issues, needs, responses, challenges and implications for policy and practice. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 22 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl). Luxembourg: Publications Office of the European Union.

Millar, Tim and McAuley, Andrew [EMCDDA] . (2017) EMCDDA assessment of drug-induced death data and contextual information in selected countries. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 82 p.

Bretteville-Jensen, Anne Line and Costa Storti, Claudia and Kattau, Thomas and Mikulic, Sania and Trigueiros, Fatima and Papamalis, Fivos and Piscociu, Laura and Tsarev, Sergey [EMCDDA] . (2017) Public expenditure on supply reduction policies. Brussels: Council of Europe. 37 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EMCDDA Best practice portal. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Montanari, Linda and Mravcik, Viktor and Grohmannova, Katerina and Royuela, Luis [EMCDDA] . (2017) European questionnaire on drug use among prisoners (EQDP). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 19 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Legal approaches to drugs and driving. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Communities That Care (CTC): a comprehensive prevention approach for communities. Luxembourg: Publications Office of the European Union. 28 p. DOI:10.2810/972747

Fountain, Jane and Burkhart, Gregor and Montanari, Linda [EMCDDA] . (2017) Implementation of drug-, alcohol- and tobacco-related brief interventions in the European Union Member States, Norway and Turkey. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 32 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 51 p. Risk Assessments 19

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Healthy nightlife toolbox.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EU Justice and Home Affairs agencies’ cooperation in 2017. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 40 p.

Christin, Nicolas [EMCDDA] . (2017) An EU-focused analysis of drug supply on the AlphaBay marketplace. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Christin, Nicolas [EMCDDA] . (2017) An EU-focused analysis of drug supply on the online anonymous marketplace ecosystem. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 25 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) National drug-related public expenditure online resource. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA. Luxembourg: Publications Office of the European Union. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) EMCDDA–Europol 2015 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union. 26 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Hepatitis C among drug users in Europe: epidemiology, treatment and prevention. Luxembourg: Publications Office of the European Union. 104 p. EMCDDA Insights 23

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). Luxembourg: Publications Office of the European Union. 48 p. Risk Assessments 18

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Health responses to new psychoactive substances. Luxembourg: Publications Office of the European Union. 30 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Perspectives on drugs: Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Perspectives on drugs: health responses to new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology. Luxembourg: Publications Office of the European Union. 18 p.

Strang, John and McDonald, Rebecca, eds. [EMCDDA] (2016) Preventing opioid overdose deaths with take-home naloxone. Luxembourg: Office for Official Publications of the European Communities. 104 p. EMCDDA Insights Series no. 20

England, Kathleen [EMCDDA] . (2016) Codification practices of drug related deaths following the WHO revision of ICD coding guidelines related to DRDs – Part I. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 39 p.

England, Kathleen [EMCDDA] . (2016) A review of the inventory of the national Special Mortality Registries in Europe with a focus on information flow to the General Mortality Registries – Part II. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 27 p.

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2015) EMCDDA–Europol joint report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP). Luxembourg: Publications Office of the European Union. 26 p.

European Monitoring Centre for Drugs and Drug Addiction. Buhler, Anneke and Thrul, Johannes [EMCDDA] . (2015) Prevention of addictive behaviours. Luxembourg: Publications Office of the European Union. 104 p. EMCDDA Insights Series no. 18

Hibell, Bjorn and Molinaro, Sabrina and Siciliano, Valeria and Kraus, Ludwig [EMCDDA] . (2015) The ESPAD validity study in four countries in 2013. Luxembourg: Office for Official Publications of the European Communities. 41 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Drugs policy and the city in Europe. Luxembourg: Office for Official Publications of the European Communities. 25 p. EMCDDA Papers

Sarasa-Renedo, Ana and Barrio, Gregorio and Montanari, Linda and Guarita, Bruno and de La Fuente, Luis and Bravo, Maria Jose and Vicente, Julian [EMCDDA] . (2015) Estimating trends in injecting drug use in Europe using national data on drug treatment admissions. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 35 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) New psychoactive substances in Europe: Innovative legal responses. Luxembourg: Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Legal approaches to controlling new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Models for the legal supply of cannabis: recent developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: opioid trafficking routes from Asia to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The misuse of benzodiazepines among high-risk opioid users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The role of psychosocial interventions in drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Wastewater analysis and drugs — a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Hepatitis C treatment for injecting drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Injection of synthetic cathinones. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Preventing overdose deaths in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Synthetic drug production in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The EU drugs strategy (2013–20). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Mortality among drug users in Europe: new and old challenges for public health. Luxembourg: Office for Official Publications of the European Communities. 21 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Emergency health consequences of cocaine use in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Health and social responses for methamphetamine users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Internet-based drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: New developments in Europe's cannabis market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Treatment for cocaine dependence — reviewing current evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. Vanderplasschen, Wouter and Vandevelde, Stijn and Broekaert, Eric [EMCDDA] . (2014) Therapeutic communities for treating addictions in Europe. Luxembourg: Publications Office of the European Union. 95 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) The levels of use of opioids, amphetamines and cocaine and associated levels of harm: summary of scientific evidence. Luxembourg: Office for Official Publications of the European Communities. 53 p.

European Monitoring Centre for Drugs and Drug Addiction. Brotherhood, Angelina and Sumnall, Harry [EMCDDA] . (2013) European drug prevention quality standards: a quick guide. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 38 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2013) Models of addiction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 166 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2013) Perspectives on drugs: Can mass media campaigns prevent young people from using drugs? Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

[EMCDDA] (2013) Drug-related research in Europe webpage. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2013) Treatment options for cannabis users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Standards and guidelines for practices. Web resource. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Prisons and drugs in Europe: the problem and responses. Luxembourg: Publications Office of the European Union. 36 p.

European Monitoring Centre for Drugs and Drug Addiction. Sumnall, Harry and Brotherhood, Angelina [EMCDDA] . (2012) Social reintegration and employment: evidence and interventions for drug users in treatment. Luxembourg: Publications Office of the European Union. 208 p.

[EMCDDA] (2012) Harm reduction overview for Ireland. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 140 p.

[EMCDDA] (2012) Best Practice Portal: Harm reduction interventions for opioid injectors. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2012) Best Practice Portal: Harm reduction interventions for smoking and inhaling drug use. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2012) Evidence of efficacy: Prevention interventions for families. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA: Prevention profile: Ireland. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Overviews of legal topics. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: classification of controlled drugs. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: penalties for illegal drug trafficking. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA Trendspotter study on fentanyl in Europe. Luxembourg: Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union. 40 p.

[EMCDDA] (2012) Evidence of efficacy: prevention interventions. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: possession of cannabis for personal use. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2012) Treatment options for amphetamines users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2012) Treatment options for cocaine users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] (2012) Treatment options for opioid users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC. 55 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Guidelines for the treatment of drug dependence: a European perspective. Luxembourg: Publications Offi ce of the European Union. 30 p. 10.2810/49457

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Hepatitis and drug use.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control. 55 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 4. Prevention and evaluation resources kit (PERK). Luxembourg: The Publications Office of the European Union. 100 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 5. Guidelines for collecting data on retail drug prices in Europe: issues and challenges. Luxembourg: The Publications Office of the European Union. 136 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 6. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. A manual for provider-initiated voluntary medical examination, testing and counselling. Luxembourg: The Publications Office of the European Union. 75 p.

[EMCDDA] (2010) Harm reduction interventions for stimulant injectors. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups. Wiegand, Caren and Weilandt, Caren and MacDonald, Morag and Popov, Ivan and Purvlice, Baiba and Pavlovska, Linda and Parausanu, Emanual and Dobrota, Sorin [EMCDDA] . (2010) Prison staff and harm reduction: a training manual. Bonn: Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups. 261 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2007) Guidelines for the evaluation of treatment in the field of problem drug use; a manual for researchers and professionals. Luxembourg: Office for Official Publications of the European Communities. 76 p.

Buhler, Anneke and Kroger, Christoph [EMCDDA] . (2006) Report on prevention of substance abuse. Cologne: Federal Centre for Health Education (BZgA). 144 p. Research and Practice of Health Promotion, Volume 29

Canning, Una and Millward, Louise and Raj, Thara and Warm, Daniel [EMCDDA] . (2004) Drug use prevention among young people: a review of reviews. London: Health Development Agency. 72 p.

Hawks, David and Scott, Katie and McBride, Myanda [EMCDDA] . (2002) A selected review of what works in the area of prevention. Geneva: World Health Organization.

This list was generated on Mon Apr 23 03:08:39 2018 GMT.